Compound 11 was a selective inhibitor of CYP11B1 that is the principal enzyme for the production of cortisol, which inhibition may be a strategy for the treatment of Cushing's syndrome and delayed wound healing (Nieman, 2002). The gene discussed is CYP11B1; the disease is Cushing syndrome.